They'll wait for the capital raise until FDA approval for Phase III trial in Quarter 1 CY2024, IMO.
Cash burn will decrease now that the Phase II is pretty much finished, so I expect 4th quarter 2023 to be a relatively low burn quarter cf recent quarters.
- Forums
- ASX - By Stock
- PAR
- PAR. SP
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.76%
!
44.0¢

PAR. SP, page-247
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
44.0¢ |
Change
0.020(4.76%) |
Mkt cap ! $178.8M |
Open | High | Low | Value | Volume |
42.5¢ | 46.0¢ | 42.0¢ | $347.2K | 796.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 25262 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.5¢ | 228 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2292 | 0.480 |
1 | 22 | 0.465 |
1 | 4500 | 0.455 |
2 | 10137 | 0.450 |
4 | 30829 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 51222 | 4 |
0.455 | 17449 | 3 |
0.460 | 29978 | 2 |
0.465 | 112360 | 2 |
0.470 | 87163 | 5 |
Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online